JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New arthritis drug trial for kids: could filgotinib help?
Disease control TerminatedThis study is testing the drug filgotinib in children aged 8 to 17 with juvenile idiopathic arthritis (JIA), a condition causing joint pain and swelling. The goal is to see how the drug moves through the body and if it is safe. Ten children with moderate to severe JIA that is not…
Matched conditions: JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE1 • Sponsor: Alfasigma S.p.A. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
Gut microbiome study in kids with autoimmune diseases ends early
Knowledge-focused TerminatedThis study aimed to compare the gut bacteria of children newly diagnosed with juvenile idiopathic arthritis, type 1 diabetes, or inflammatory bowel disease with those of their healthy siblings. Researchers wanted to see if differences in gut microbes and diet could explain why so…
Matched conditions: JUVENILE IDIOPATHIC ARTHRITIS
Sponsor: University Hospital, Clermont-Ferrand • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC